Ji Jiang

3.0k total citations
195 papers, 2.3k citations indexed

About

Ji Jiang is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Ji Jiang has authored 195 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 42 papers in Oncology and 27 papers in Pharmacology. Recurrent topics in Ji Jiang's work include Analytical Methods in Pharmaceuticals (22 papers), Lung Cancer Treatments and Mutations (19 papers) and Antibiotics Pharmacokinetics and Efficacy (17 papers). Ji Jiang is often cited by papers focused on Analytical Methods in Pharmaceuticals (22 papers), Lung Cancer Treatments and Mutations (19 papers) and Antibiotics Pharmacokinetics and Efficacy (17 papers). Ji Jiang collaborates with scholars based in China, United States and United Kingdom. Ji Jiang's co-authors include Pei Hu, Qian Zhao, Dongyang Liu, Hongyun Wang, Hongyun Wang, Sheng Feng, Jing Lu, Wen Zhong, Xia Chen and Fenlai Tan and has published in prestigious journals such as Journal of Clinical Oncology, Environmental Science & Technology and Blood.

In The Last Decade

Ji Jiang

189 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ji Jiang China	24	655	463	349	237	232	195	2.3k
Miao Yan China	22	657 1.0×	215 0.5×	288 0.8×	133 0.6×	279 1.2×	146	2.0k
David A. Vesey Australia	31	818 1.2×	214 0.5×	261 0.7×	294 1.2×	65 0.3×	118	3.3k
Zhigang Yu China	34	1.5k 2.4×	652 1.4×	249 0.7×	255 1.1×	216 0.9×	150	4.5k
Giuliano Ciarimboli Germany	31	834 1.3×	1.6k 3.6×	242 0.7×	136 0.6×	157 0.7×	95	3.3k
Ken‐ichi Miyamoto Japan	32	848 1.3×	769 1.7×	189 0.5×	295 1.2×	167 0.7×	164	2.9k
Roberto Padrini Italy	27	402 0.6×	447 1.0×	203 0.6×	343 1.4×	646 2.8×	104	2.7k
Marjorie Romkes United States	30	941 1.4×	573 1.2×	293 0.8×	175 0.7×	435 1.9×	85	3.3k
Jianping Zhang China	28	852 1.3×	502 1.1×	161 0.5×	117 0.5×	301 1.3×	114	2.3k
Fernando Pérez‐Barriocanal Spain	24	611 0.9×	221 0.5×	277 0.8×	171 0.7×	153 0.7×	60	2.0k

Countries citing papers authored by Ji Jiang

Since Specialization

Citations

This map shows the geographic impact of Ji Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Jiang more than expected).

Fields of papers citing papers by Ji Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Jiang. The network helps show where Ji Jiang may publish in the future.

Co-authorship network of co-authors of Ji Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Ji Jiang. A scholar is included among the top collaborators of Ji Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji Jiang. Ji Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Zhiguo, Yan Dong, Li Li, et al.. (2024). AXIN1/MYC Axis Mediated the Osimertinib Resistance in EGFR Mutant Non-Small Cell Lung Cancer Cells. The Tohoku Journal of Experimental Medicine. 262(4). 269–276.

Jiang, Ji, et al.. (2023). P761: UMBILICAL CORD BLOOD ORIGIN CELLS RECONSTRUCT THE HEMATOPOIESIS OF APLASTIC ANEMIA ANIMAL MODEL. HemaSphere. 7(S3). e37995d8–e37995d8. 1 indexed citations

Dai, Yang, Yan Wang, Xinyue Yang, et al.. (2023). Assessment of post-COVID-19 fatigue among female survivors 2 years after hospital discharge: a nested case–control study. BMC Public Health. 23(1). 2455–2455. 3 indexed citations

Jiang, Ji, et al.. (2023). Eltrombopag with or without Tacrolimus for relapsed/refractory acquired aplastic anaemia: a prospective randomized trial. Blood Cancer Journal. 13(1). 146–146.

Yao, Xueting, Yupeng Ren, Qian Zhao, et al.. (2021). Pharmacokinetics analysis based on target-mediated drug distribution for RC18, a novel BLyS/APRIL fusion protein to treat systemic lupus erythematosus and rheumatoid arthritis. European Journal of Pharmaceutical Sciences. 159. 105704–105704. 15 indexed citations

Jiang, Ji, et al.. (2020). Evaluation of Therapeutic Equivalence for the Follow-On Version of Intravenously Administered Non-Biological Complex Drugs. Clinical Pharmacokinetics. 59(8). 995–1004. 7 indexed citations

Xu, Xiao, Wanhong Xu, Wei Tang, et al.. (2016). AC0010, an Irreversible EGFR Inhibitor Selectively Targeting Mutated EGFR and Overcoming T790M-Induced Resistance in Animal Models and Lung Cancer Patients. Molecular Cancer Therapeutics. 15(11). 2586–2597. 69 indexed citations

Zheng, Xin Xiao, et al.. (2016). Validation and Application of an LC–MS-MS Method for the Determination of Ceftizoxime in Human Serum and Urine. Journal of Chromatographic Science. 54(5). 713–719. 8 indexed citations

Zhao, Qian, Xia Chen, Yong Hou, et al.. (2015). Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT‐18 in Chinese Patients With Systemic Lupus Erythematosus. The Journal of Clinical Pharmacology. 56(8). 948–959. 21 indexed citations

10.

Jiang, Ji. (2014). Observational Research on Planetary Boundary Layer by Lidar Over Nanjing City. Environmental Science & Technology. 6 indexed citations

11.

Jiang, Ji. (2013). Quantitative determination of 1-Deoxynojirimycin in San-Ye tablets by HPLC-MS/MS. 1 indexed citations

12.

Jiang, Ji. (2013). Inhibiting Effect of Ultra-micro Powder Qiweibaizhusan on Bacteria in Vitro. Zhongguo zhongyiyao xinxi zazhi. 2 indexed citations

13.

Wang, Hanping, Li Zhang, Fenlai Tan, et al.. (2011). Phase I trial of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in Chinese patients with non-small cell lung cancer.. PubMed. 124(13). 1933–1933. 31 indexed citations

14.

Jiang, Ji. (2011). A NEW SPECIES OF VITRONURA YOSII,1969 (COLLEMBOLA,NEANURIDAE) FROM NORTHWESTERN CHINA. Acta Zootaxonomica Sinica. 1 indexed citations

15.

Jiang, Ji, Dongyang Liu, & Pei Hu. (2009). Pharmacokinetic and safety profile of olmesartan medoxomil in healthy Chinese subjects after single and multiple administrations.. PubMed. 64(5). 323–6. 6 indexed citations

16.

Zhao, Qian, Ji Jiang, Xiaoming Li, Zhihong Lu, & Pei Hu. (2007). Single‐dose pharmacokinetics of levetiracetam in healthy Chinese male subjects. British Journal of Clinical Pharmacology. 63(5). 614–617. 19 indexed citations

17.

Jiang, Ji. (2005). Inhibition of Plant Extracts on Growth of Strawberry Root Rot Fungi. Journal of Hebei University. 2 indexed citations

18.

Yang, Yuexin, et al.. (2003). Metabolism of resistant starch and its regulative effect on plasma glucose. Acta Nutrimenta Sinica. 25(2). 190–195. 1 indexed citations

19.

Jiang, Ji. (2001). Analysis on the factors influencing the length of hospital stay in the diabetic inpatients. Chinese Journal of Disease Control and Prevention. 1 indexed citations

20.

Jiang, Ji. (2001). RESISTANCE TO Phytophthora infestans IN POTATO INDUCED WITH PLANT EXTRACTS. Acta Phytopathologica Sinica. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact